Consistent with our chromatin-based MS V2G results and the eQTL co-localization analyses, FDTF1 is significantly upregulated in CD4 + T cells from MS patients, as well as in naïve B cells, circulating GCB cells (plasmablasts), NK cells, monocytes, and Treg (Fig. 4E). The gene discussed is CD4; the disease is myeloid sarcoma.